Browsing Tag
Anifrolumab
1 post
Anifrolumab (Saphnelo) Gets Green Light for Approval in EU
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorization for anifrolumab (Saphnelo) as an add-on treatment for adults with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite standard therapy, according to an announcement on Dec. 16. Anifrolumab, a monoclonal antibody that binds to subunit 1 of the…